Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Grünenthal Ltd., 1 Stokenchurch Business Park, Ibstone Road, Stokenchurch, England, HP14 3FE, UK
ZYDOL 50mg Soluble Tablets.
| Pharmaceutical Form |
|---|
|
White to near white, round, flat tablets with bevelled edges, characteristic peppermint odour, engraved with ‘T4’ on one side, manufacturer’s logo on the other. |
Each ZYDOL soluble tablet contains 50 mg tramadol hydrochloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tramadol |
Tramadol is a centrally acting opioid analgesic. It is a non selective pure agonist at μ-, δ- and κ-opioid receptors with a higher affinity for the μ-receptor. Other mechanisms which may contribute to its analgesic effect are inhibition of neuronal reuptake of noradrenaline and enhancement of serotonin release. Tramadol has an antitussive effect. In contrast to morphine, analgesic doses of tramadol over a wide range have no respiratory depressant effect. |
| List of Excipients |
|---|
|
ZYDOL soluble tablets contain: Microcrystalline cellulose |
Aluminium/Polypropylene foil blisters.
Pack sizes of 10, 20 or 100 tablets.
Not all pack sizes may be marketed.
Grünenthal Ltd., 1 Stokenchurch Business Park, Ibstone Road, Stokenchurch, England, HP14 3FE, UK
PL 21727/0006
14 February 2002
| Drug | Countries | |
|---|---|---|
| ZYDOL | Australia, Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
